A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration — Stella
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(13 sites)
United States
Associated Retina Consultants - Peoria- Site Number : 8400011, Peoria, Arizona
Retina Macula Institute of Arizona- Site Number : 8400028, Scottsdale, Arizona
Vitreo Retinal Associates - Gainesville- Site Number : 8400004, Gainesville, Florida
Retina Vitreous Associates of Florida - St. Petersburg- Site Number : 8400002, St. Petersburg, Florida
University Retina - Lemont- Site Number : 8400005, Lemont, Illinois
The Retina Group of Washington - Chevy Chase- Site Number : 8400009, Chevy Chase, Maryland
Cumberland Valley Retina Consultants - Hagerstown- Site Number : 8400003, Hagerstown, Maryland
Oregon Retina- Site Number : 8400017, Eugene, Oregon
Mid Atlantic Retina- Site Number : 8400031, Bethlehem, Pennsylvania
Austin Clinical Research - Austin - Anderson Mill Road- Site Number : 8400007, Austin, Texas
Retina Foundation of the Southwest- Site Number : 8400001, Dallas, Texas
Texas Retina Associates - Dallas- Site Number : 8400006, Dallas, Texas
Retinal Consultants of Texas - San Antonio- Site Number : 8400012, San Antonio, Texas